Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ZBIO

Zenas BioPharma, Inc.

Healthcare | Biotechnology

No licensed closing price on file for ZBIO. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 05:23 UTC.

What Zenas BioPharma, Inc. does

This company is a clinical-stage biopharmaceutical firm developing immunology-based therapies for autoimmune diseases. Its lead product candidate, obexelimab, is a monoclonal antibody designed to inhibit B cells implicated in autoimmune disease without depleting them; it has been evaluated in eight clinical trials and has demonstrated clinical activity and tolerability.

Summarized from Zenas BioPharma, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
Return on equity-156.00%
Debt/equity0.32

Revenue, margins & earnings

FY2023: net loss $37M on revenue $50M$50MFY2023FY2024: net loss $157M on revenue $5M$5MFY2024FY2025: net loss $378M on revenue $10M$10MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-02
  • 2026-09-02DirectorStock Option (Right to Buy)Award37,000—
  • 2026-06-17See RemarksStock Option (Right to Buy)Award175,000—
  • 2026-06-17See RemarksAward974$13.0K
Sign in to see all transactions →

Company news

View all →

Questions this page answers

What does Zenas BioPharma, Inc. do?

This company is a clinical-stage biopharmaceutical firm developing immunology-based therapies for autoimmune diseases.

When did ZBIO last file with the SEC?

Zenas BioPharma, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-05-13. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:23 UTC. This page is also available as JSON at /api/data?ticker=ZBIO and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ZBIO and 5,000+ tickers.

Create a free account — keep ZBIO
For your agent
GET /api/data?ticker=ZBIO

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt